Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice by van Wyk, Michiel et al.
Retinitis pigmentosa (RP) is a heterogenic hereditary 
disease resulting in progressive photoreceptor loss, eventu-
ally leading to blindness. Recent advances in gene therapy 
and optogenetics have led to promising therapeutic strategies 
for patients with RP and, accordingly, to a sharp rise in the 
use of RP mouse models [1-3]. The genetic diversity of RP in 
humans, which may affect more than 100 individual genes, 
is reflected in the large collection of retinal degeneration (rd) 
mutations available in RP mouse models [4]. Most vision 
recovery studies, however, use the retinal degeneration 1 
(rd1, rodless, Pde6brd1) mouse, with a homozygous nonsense 
mutation in exon 7 (codon 347) of the Pde6b gene correlated 
with deficient activity of the rod cGMP-phosphodiesterase, 
as well as a murine leukemia provirus insertion in intron 1 
of the same gene [5,6]. The popularity of the rd1 model can 
be attributed to several factors: (1) It was the first identified 
model of RP [7], (2) its phenotype resembles that of human 
patients with RP with the Pde6b mutation, accounting for 
approximately 4% of all RP cases [8-10], (3) it has become a 
standard model, making comparisons between studies easier, 
and (4) it is an accessible model with a high prevalence in 
laboratory mice.
Currently, more than 100 mouse lines carry the rd1 
mutation, allowing experimenters to choose the genetic 
background according to their needs, for example, reliable 
breeders with large litters, pigmented or albino mice, avail-
ability at the local husbandry, and so forth. Despite the pivotal 
role of disease progression at the time point of therapeutic 
intervention and the knowledge of variable phenotypic 
expressivity in human RP patients [11] as well as evidence 
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Purpose: Recent advances in optogenetics and gene therapy have led to promising new treatment strategies for blindness 
caused by retinal photoreceptor loss. Preclinical studies often rely on the retinal degeneration 1 (rd1 or Pde6brd1) retinitis 
pigmentosa (RP) mouse model. The rd1 founder mutation is present in more than 100 actively used mouse lines. Since 
secondary genetic traits are well-known to modify the phenotypic progression of photoreceptor degeneration in animal 
models and human patients with RP, negligence of the genetic background in the rd1 mouse model is unwarranted. 
Moreover, the success of various potential therapies, including optogenetic gene therapy and prosthetic implants, depends 
on the progress of retinal degeneration, which might differ between rd1 mice. To examine the prospect of phenotypic 
expressivity in the rd1 mouse model, we compared the progress of retinal degeneration in two common rd1 lines, C3H/
HeOu and FVB/N.
Methods: We followed retinal degeneration over 24 weeks in FVB/N, C3H/HeOu, and congenic Pde6b+ seeing mouse 
lines, using a range of experimental techniques including extracellular recordings from retinal ganglion cells, PCR 
quantification of cone opsin and Pde6b transcripts, in vivo flash electroretinogram (ERG), and behavioral optokinetic 
reflex (OKR) recordings.
Results: We demonstrated a substantial difference in the speed of retinal degeneration and accompanying loss of visual 
function between the two rd1 lines. Photoreceptor degeneration and loss of vision were faster with an earlier onset in 
the FVB/N mice compared to C3H/HeOu mice, whereas the performance of the Pde6b+ mice did not differ significantly 
in any of the tests. By postnatal week 4, the FVB/N mice expressed significantly less cone opsin and Pde6b mRNA 
and had neither ERG nor OKR responses. At 12 weeks of age, the retinal ganglion cells of the FVB/N mice had lost all 
light responses. In contrast, 4-week-old C3H/HeOu mice still had ERG and OKR responses, and we still recorded light 
responses from C3H/HeOu retinal ganglion cells until the age of 24 weeks. These results show that genetic background 
plays an important role in the rd1 mouse pathology.
Conclusions: Analogous to human RP, the mouse genetic background strongly influences the rd1 phenotype. Thus, 
different rd1 mouse lines may follow different timelines of retinal degeneration, making exact knowledge of genetic 
background imperative in all studies that use rd1 models.
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pointing toward variation in retinal degeneration between 
rd1 mice [12], the inf luence of genetic background has 
been largely neglected in the rd1 mouse model. Moreover, 
the genetic background of rd1 mice is often omitted from 
regenerative studies, or strains are interchangeably referred 
to as Pde6b−/− [13-16].
In summary, the progress of retinal degeneration is 
considered identical in rd1 mice: Degeneration starts with the 
fast onset of rod dystrophy at postnatal day (P) 8–10 [17-19]. 
By 3–4 weeks of age, all rod photoreceptors are lost, and a 
single layer of photoreceptors consisting of cones remains 
that are subsequently lost through secondary unknown 
mechanisms [17,18,20-22]. The outer segments of the cones 
are misshaped and presumably dysfunctional, which mani-
fests in an undetectable electroretinogram (ERG) at P21 
[23] and a total loss of image-forming vision by P40 [17]. To 
address the important question of potential variable pheno-
typic expressivity in the rd1 mouse model, we compared 
the progress of photoreceptor degeneration between the two 
strains with the highest prevalence of rd1 mutations, C3H 
and FVB [24-26]. We used the congenic C3H-Pde6b+ and 
FVB-Pde6b+ seeing mouse lines with matching genetic back-
grounds but lacking the rd1 mutation as the negative controls. 
C3H mouse lines are widely distributed for research purposes 
by most major animal suppliers worldwide. A review of more 
than 130 research articles in which the rd1 background was 
stated showed that 67% of these studies used the C3H line 
[27]. Retinal degeneration caused by the rd1 mutation was 
first characterized in the C3H/He strain [18,21,22]. In this 
manuscript, we use the substrain C3H/HeOuJ, a pigmented 
prolific general purpose strain frequently used as a model 
of retinal degeneration in vision research [3,28,29]. FVB 
mice are also popular rd1 models; more than 50 substrains 
carry the rd1 mutation [26,30-33]. In this study, we used the 
FVB/N substrain, which has been proved to be a near-perfect 
background for creating transgenic animals with pronuclear 
injection [34,35]. Not only do the egg cells have large hardy 
pronuclei that facilitate the process of pronuclear injection, 
but FVB/N mice are also highly prolific breeders, which 
allow researchers to rapidly establish transgenic lines. The 
ease of generating transgenic mice led to the creation of a 
congenic seeing counterpart, the FVB-Pde6b+ strain [36,37].
Since cone degeneration determines the ultimate onset 
of blindness, we focused primarily on the rate of cone 
degeneration and the accompanying loss of visual function 
at photopic light intensities. We followed the progress of 
retinal degeneration in both mouse lines from 3 to 24 weeks 
of age using behavioral optokinetic reflex (OKR) experi-
ments, in vivo flash ERG recordings, recordings of light 
responses from retinal ganglion cells in isolated retinas, 
cone opsin and rod photoreceptor cGMP−specific phospho-
diesterase beta−subunit (β-PDE) immunoreactivity as well 
as PCR quantification of cone opsin and Pde6b transcript 
levels. We demonstrate a marked difference in the speed of 
photoreceptor degeneration and the associated loss of visual 
function between the two rd1 lines. Degeneration was signifi-
cantly faster with an earlier onset in FVB/N compared to 
the C3H/HeOu mice. In contrast, no significant differences 
were observed between the two congenic seeing Pde6b+ lines 
in any of the tests. We conclude that, as in human patients, 
secondary genetic factors are imperative in the pathology of 
rd1 mice.
METHODS
Animals: Experiments were performed on either sex of the 
C3H/HeOuJ, FVB/NCrl and congenic seeing C3Sn.BLiA-
Pde6b+/J (C3H-Pde6b+) and FVB.129P2-Pde6b+Tyrc-ch/AntJ 
(FVB-Pde6b+) mice. All mouse lines were obtained from 
Charles River Laboratories (Sulzfeld, Germany), the Euro-
pean distributor of the Jackson Laboratory, which maintains 
its own FVB/N strain (FVB/NCrl).
The C3H parent colony was developed by L. C. Strong in 
1920 from a cross of a Bagg albino female with a DBA male 
followed by selection for high incidence of mammary tumors. 
The tumors resulted from exogenous mouse mammary tumor 
virus (MMTV) transmitted through the mother’s milk. The 
Jackson Laboratory currently maintains four rederived C3H 
substrains that have been free of exogenous MMTV since 
1999: (1) C3H/HeJ (Stock No. 000,659), (2) C3H/HeOuJ 
(Stock No. 000,635), (3) C3HeB/FeJ (Stock No. 000,658), 
and (4) C3H/HeSnJ (Stock No. 000,661). The C3H/HeSnJ 
strain was separated from the “parental” C3H/HeJ line 
before 1947, the C3HeB/FeJ line in 1948 (by embryo transfer 
to C57/BL6 surrogate mothers), and the C3H/HeOuJ line in 
1952 when it was discovered that this colony of mice carried 
the Kitw-x mutation [38]. Since Kitw-x is a homozygous lethal 
mutation, the affected colony had a mixture of heterozygous 
and homozygous animals from which the current wild-type 
C3H/HeOuJ line was derived in 1982 by Dr. H.C. Outzen. 
All C3H substrains from the Jackson Laboratory share the 
same rd1 Pde6b mutation resulting in photoreceptor degen-
eration as well as a mutation in the AHR gene resulting in 
xenobiotic sensitivity. Since their final separation in 1952 and 
close to 200 generations of breeding, we are aware of genetic 
divergence in these substrains. The C3H/HeJ substrain has 
been the most severely affected and acquired the following 
mutations: (1) a mutation in the tlr4 gene conveying endo-
toxin resistance [39], (2) an insertion in the last intron of the 
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Gria4 gene decreasing protein expression and leading to 
high susceptibility to absence seizures [40], (3) an insertion 
in intron 19 of the Pcnxl2 gene, again decreasing protein 
expression but mitigating the absence seizure phenotype [41], 
(4) an inversion covering 20% of chromosome 6, which does 
not appear to have a phenotype (Jax Notes, issue 491, Fall 
2003), and, most importantly, (5) the Gpr179nob5 insertional 
mutation in intron 1 of the Gpr179 gene that compromises 
visual function [27,42]. Over the same period, the C3HeB/FeJ 
line has acquired a mutation in the Ipr1 gene that makes the 
line highly susceptible to tuberculosis [43] while no mutations 
have been reported in the C3H/HeOuJ and C3H/HeSnJ lines, 
which are considered genetically similar.
The FVB/N line stems from an outbred colony of 
Swiss mice (N:GP general purpose strain) established at 
the National Institutes of Health in 1935. A second colony 
(N:NIH) was established from the original N:GP colony in 
the early 1940s. In 1966, a project was started to develop two 
populations of N:NIH mice, one sensitive (HSFS/N) and one 
resistant (HSFR/N) to the histamine sensitivity factor. In the 
early 1970s, while being established as an inbred strain, some 
HSFS/N mice were discovered to be sensitive to the Friend 
leukemia virus B strain. At this point, inbreeding continued 
with selection for Fv-1b homozygosity, and the strain was 
designated as FVB as an abbreviation for Friend virus B-type 
susceptibility. The FVB line was maintained as an inbred line 
without further selection and was brought to Charles River 
from the NIH in 1994 where the line has been maintained 
since. There exist no known genetic differences between the 
FVB/NCrl line from Charles River and the FVB/NJ line from 
the Jackson laboratory. In addition to the rd1 Pde6b mutation 
and the Fv-1b allele, all FVB lines carry three additional muta-
tions: (1) A frame shift in the Disc1 gene results in abnormal 
learning/conditioning [44], (2) a deletion and premature stop 
codon in the C5 gene is associated with immune deficits and 
allergen-induced bronchial hypersensitivity [45], and (3) a 
nt7778 G/T point mutation in the mitochondrial mt-ATP8 
gene [46] is correlated with anxiety-related behavior and 
increased oxidative stress [47,48].
The seeing congenic mouse lines C3A.BLiA-Pde6b+/J 
and FVB.129P2-Pde6b+ Tyrc-ch/AntJ were generated at the 
Jackson Laboratory specifically to produce control sighted 
strains on C3H/He and FVB/N backgrounds [49]. C3A.
BLiA-Pde6b+/J was generated by introducing the C57BL/
LiA-derived wild-type allele of Pde6b to the C3H/HeSnJ 
strain before offspring were backcrossed for another ten 
generations to the C3H/HeSnJ inbred mice. Due to the 
genetic identity of the C3H/HeOuJ and C3H/HeSnJ mouse 
lines, the C3A.BLiA-Pde6b+/J makes a well-suited congenic 
sighted strain for the C3H/HeOuJ rd1 mice. For generation of 
the sighted FVB.129P2-Pde6b+ Tyrc-ch/AntJ line, the 129P2/
OlaHsd-derived wild-type allele of Pde6b was introduced to 
the FVB/N background and subsequently backcrossed for 11 
generations with FVB/N mice. The first homozygous matings 
for both strains were performed in 2006.
All animal experiments were conducted in accordance 
with the Swiss Federal Animal Protection Act and the stan-
dards set forth in the ARVO Statement for the Use of Animals 
in Ophthalmic and Visual Research and were approved by the 
animal research committee of Bern (approval No BE44–12). 
Mice were housed under a 12 h:12 h light-dark cycle with 
a daily light intensity of about 7 lux, which is considered 
non-harmful to the sensitive retinas of albino mice [50]. Light 
intensity was measured inside the cage, using a light meter 
(Model PM200, Thorlabs, Munich, Germany). Mice were 
euthanized with CO2 anesthesia followed by decapitation.
Recordings from retinal ganglion cells: The methods for 
recording cell-attached light responses from retinal ganglion 
cells have been described in detail previously [12]. Mice were 
dark adapted for 1 h, and, following euthanasia, the eyes 
were enucleated under dim-red illumination and the retinas 
removed. The retina was placed in a recording chamber 
perfused with Ames medium (Sigma-Aldrich, Buchs, Swit-
zerland) at a rate of 5 ml/min, and the tissue was maintained 
at 34–36 °C (pH 7.4). The ganglion cells were targeted for 
recording under visual control using infrared differential-
interference-contrast (IR-DIC) optics. Electrodes were pulled 
from borosilicate glass to a final resistance of 5–8 MΩ and 
filled with Ames medium. Cells were approached with the 
recoding pipette until spontaneous action potentials were 
observed in the voltage recording. Blue light (λ=470 nm) 
flash stimuli were generated with a pE-2 system (CoolLED, 
Andover, UK) and projected through a 40X water immersion 
objective onto the receptive field of the recorded ganglion 
cell. The background light intensity was kept near zero. The 
stimulus light intensity was set to 3.2×1017 photons cm−2 s−1. 
The stimulus was presented 5 times to evaluate whether the 
action potentials were modulated consistently. Spike-time 
histograms with 100 ms bins were generated from all five 
traces. Cells were classed as light responsive if there was a 
significant change in firing frequency between at least two 
bins generated before and after the onset of the light stimulus.
Optokinetic reflex measurements: The OptoMotry system 
from CerebralMechanics (Lethbridge, Canada) was used 
to measure the OKR with the method described previously 
[51,52]. A virtual cylinder comprising a vertical sine wave 
grating was projected in three-dimensional (3D) coordi-
nate space on four computer monitors (Dell 1703FP, Bern, 
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Switzerland) facing a 13-cm-high platform above a mirrored 
f loor under a likewise mirrored lid. The light intensity 
measured at the center of the platform was 5.6 × 1013 photons 
cm−2 s−1. During testing, the mice stood unrestrained on the 
platform tracking the 3D pattern with a reflexive head move-
ment that was recorded with a video camera (DCR-HC26, 
Sony, Bern, Switzerland). The movements of the mice on the 
platform were followed by two independent experimenters. 
The spatial frequency of the test grating was changed in steps 
until the highest spatial tracking frequency was identified 
as the threshold (visual acuity). A minimum spatial acuity 
of 0.003 cycles per degree was assigned to all mice with no 
detectable OKR reflex.
Electroretinography: All procedures were performed under 
dim-red illumination. We anesthetized the mice with an 
intraperitoneal injection of 100 mg/kg ketamine and 10 mg/
kg xylazine and dilated the pupils of both eyes using a drop of 
10 mg/ml atropine sulfate (Théa Pharma, Clermont-Ferrand, 
France). Animals were subsequently placed on a temperature-
controlled heating table inside a Q400 full-field bowl (Roland 
Consult, Brandenburg, Germany). We recorded from both 
eyes using gold wire electrodes wetted with 1% methylcellu-
lose that circled the corneal borders (OmniVision, Puchheim, 
Germany). Needle electrodes placed under the skin of the 
cheeks were used as reference electrodes while a third needle 
electrode positioned in the base of the tail served as a ground 
electrode. Responses to strobe flashes were amplified, aver-
aged, and stored using a RetiScan-RetiPort electrophysiology 
unit (Roland Consult).
Immunocytochemistry: Whole mount retinas were incubated 
for 1 h in a blocking solution containing 2% donkey serum 
and 1% Triton X-100 in PBS (1X; 137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4). Retinas 
were then incubated for 5 days at 4 °C in blocking solution 
containing 1:500 primary goat anti-OPN1 SW antibody 
(Santa Cruz, Santa Cruz, CA, sc-14365), followed by a 1-h 
washing step and overnight incubation at 4 °C in blocking 
solution containing 1:400 donkey anti-goat-Cy3 secondary 
antibody (Millipore, AP180C, Schwalbach, Germany). 
Photomicrographs of opsin-stained retinas were taken from 
the midperipheral retinal where the cone density was highest 
using either on a Nikon Eclipse epifluorescence microscope 
(Nikon, Amsterdam, Netherlands) or on a LSM5 (Carl Zeiss, 
Jena, Germany) laser scanning microscope. Image contrast 
was manipulated using ImageJ [53].
Genotyping: To extract genomic DNA for PCR, toe clippings 
were lysed overnight in a buffer containing 10 mM Tris, 
100 mM NaCl, 10 mM EDTA, 0.5% sodium dodecyl sulfate 
(SDS), and 0.75 µg/ml Proteinase K (pH 8.0). The lysate was 
purified using silica spin columns (Macherey-Nagel, Oens-
ingen Switzerland). Genotyping for the murine leukemia 
viral insertion was done using the standard 3-primer protocol 
[54]. Three hundred base pairs flanking the position of the 
nonsense mutation in codon 347 were amplified using Pittler 
and Baehr’s protocol [6]. This PCR product was purified and 
sequenced at MycroSynth AG (Balgach, Switzerland) and 
additionally digested with DdeI, since the rd1 allele contains 
an additional DdeI restriction site not present in the wild-type 
allele [6].
Quantitative reverse-transcription PCR: We extracted total 
RNA from mouse retinas using the SV Total RNA Isolation 
Kit (Promega, Dübendorf, Switzerland) and ran one-step 
quantitative reverse-transcription PCR (qPCR) reactions 
(40 cycles) with 20 ng total RNA using the KAPA SYBR 
FAST One-Step Universal Kit (Kapa Biosystems, London, 
UK) on an Eco Real-Time PCR System (Illumina Inc., San 
Diego, CA). Values obtained for Opn1sw (S-opsin) mRNA 
(F 5′-CTG CTA GCA GCA AAC ACA ACG-3′, R 5′-GCT 
ACA GGC AGA GAG TAA CAG-3) and Pde6b mRNA levels 
(primers spanning exon 7, F 5′-GGC CGG GAA ATT GTC 
TTC TAC-3′ containing exon 5 and 6 sequences, R 5′-CCC 
CAG GAA CTG TGT CAG AGA-3′ containing exon 9 and 
10 sequences [55]) were normalized against β-Actin-mRNA 
levels (F 5′-CGG CAT CGT CAC CAA CTG-3′, R 5′-AAC 
ATG ATC TGG GTC ATC TTC TC-3′). For comparison of 
S-opsin expression, the Opn1sw mRNA level in the wild-type 
C57/BL6 mice was set to 1, and the values obtained from the 
C3H/HeOu and FVB/N retinas were illustrated as a fraction 
of the wild-type value. To compare Pde6b mRNA levels, the 
level of Pde6b expression in C3H-Pde6b+ mice was set to 1.
β-PDE western blotting: Two to three mice were sacrificed, 
the retinas removed, and protein extracted with 30 min 
incubation in cell lysis buffer supplemented with a protease 
inhibitor cocktail (Roche). After centrifugation for 10 min at 
1,000 ×g at 4 °C, the protein content of the supernatant was 
determined with a BCA Kit (Thermo Scientific). Aliquots 
containing 20 μg of protein were denatured by incubation in 
Laemmli buffer (Sigma) for 5 min at 100 °C and subjected 
to SDS–polyacrylamide gel electrophoresis (PAGE) using a 
4–20% gradient gel BioRad, Cressier, Swizterland). Proteins 
were transferred onto a 0.2 μm polyvinylidene fluoride 
(PVDF) membrane (Biorad) and blocked in 5% non-fat dried 
milk. The blots were incubated overnight at 4 °C with anti-β−
PDE polyclonal antibody (Antibodies online, ABIN122848, 
1:2,000) against the N-terminal amino acid residues 20–36 
from the mouse β−PDE protein and anti-GAPDH mono-
clonal antibody (Fitzgerald, Newmarket, UK, 10R-G1099 
1:100,000) followed by incubation in horseradish peroxidase 
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(HRP)-conjugated secondary anti-rabbit or anti-mouse 
(1:1,000, Jackson Immuno Research Europe Ltd, Suffolk, 
UK) antibodies for 1 h at room temperature. Finally, the 
blots were developed with SuperSignal West Dura Extended 
Substrate (Thermo Scientific, 34,075) for detection of HRP 
enzymatic activity. The apparent molecular weights of the 
probed proteins were estimated from the position of the Preci-
sion Plus standard markers (BioRad, 161–0374).
Statistical analysis: Statistics were performed in Microsoft 
Excel or NCSS statistics software. All analyzed data sets 
had normal distributions (verified using the Kolmogorov–
Smirnov test). Differences between the rd1 and Pde6b+ mouse 
lines were analyzed using an unpaired one-tailed Student 
t-test not assuming equal variance, and differences between 
the C3H/HeOu and FVB/N rd1 or Pde6b+ lines were analyzed 
with an unpaired, two-tailed Student t- test assuming equal 
variance. In the figures, significance of p<0.05 is indicated 
by an asterisk. Average values are indicated ± standard error, 
unless otherwise indicated. Fit functions and R-square values 
are indicated in the figure legends.
RESULTS
We observed more remaining photoreceptor nuclei in the 
retinal sections of the young, 3-week-old C3H/HeOu mice 
compared to the FVB/N mice (Figure 1A,B). Although the 
FVB/N retinas contained only one remaining row of photore-
ceptors, in line with previous reports for rd1 mice [18,56], the 
outer nuclear layer (ONL) of the retinas from the 3-week-old 
C3H/HeOu mice was still approximately two to three rows 
thick. At 23 weeks of age, the ONL in both strains was only 
one cell layer thick (Figure 1C,D). We also observed differ-
ences in the morphologies of the cone outer segments (OS). 
The OS in retinas from the 3-week-old FVB/N mice were 
deformed and mostly spherical (Figure 1B,F), while they were 
more ordered and cylindrical in the young C3H/HeOu retinas 
(Figure 1A,E). At 23 weeks, all OS were lost in the FVB/N 
retinas with only a few misshaped, spherical OS remaining 
in the C3H/HeOu mice (Figure 1G,H). The loss of cone OS 
coincided with the accumulation of opsin in the cell bodies.
To confirm that both mouse lines carried the same rd1 
Pde6b allele, we performed PCR to probe for the presence of 
the Tyr347 point mutation and the provirus XMV28 insertion 
in intron 1 of the Pde6b gene. As apparent from the results 
depicted in Figure 2, the C3H/HeOu and FVB/N strains were 
rd1 with identical mutations in Pde6b.
To compare the morphological and functional degenera-
tion over time in the two strains in more detail, we performed 
immunocytochemistry, ERG, and electrophysiological 
recordings as well as in vivo OKR experiments in parallel 
in the FVB/N and C3H/HeOu mice at 4 week intervals 
from 4 to 24 weeks of age. We used seeing FVB-Pde6b+ and 
C3H-Pde6b+ mice restricted to a single age group of 7–8 
weeks as controls, since the likelihood of an age-related effect 
in these two strains was considered low.
Quantification of Pde6b mRNA and β-PDE expression: To 
examine if degeneration in FVB/N mice starts earlier than in 
C3H/HeOu mice, we performed reverse transcription qPCR 
quantification of Pde6b transcripts in retinal homogenates 
of young, 3-week-old rd1 mice. β-PDE is expressed only 
in rod photoreceptors and therefore is used as an indicator 
of remnant rods [57]. Pde6b mRNA transcripts were still 
detectable in both rd1 lines (compared to C57/BL6: FVB/N 
1.0±0.5%, n=7; C3H/HeOu 11.6±2.1%, n=8), indicating that 
some rod photoreceptors still remained but at significantly 
lower numbers compared to the congenic Pde6b+ control 
mice (C3H-Pde6b+ 89±11%, FVB-Pde6b+ 100±24%, n=8; 
Figure 3A,B). More importantly, the Pde6b transcript levels 
in the FVB/N retinas were significantly reduced compared to 
those in the C3H/HeOu retinas, corroborating the relatively 
progressed rod degeneration shown in Figure 1B. Since 
a gene’s mRNA level does not predict protein levels, we 
also performed high-sensitivity chemiluminescent western 
blotting for β-PDE. The retinal protein extracts from the 
rd1, Pde6b+, and C57/BL6 mice (used as a positive internal 
control) were probed with an N-terminal anti-β-PDE antibody 
(AA residues 20–36). β-PDE immunoreactivity to the full-
length protein of approximately 86 kDa was visualized to 
similar amounts in extracts from the Pde6b+ and C57/BL6 
retinas (Figure 3C). In contrast and in line with previous 
reports [56], no such immunoreactivity was detected in either 
rd1 line (FVB/N or C3H/HeOu), to neither full-length nor 
truncated 38 kDa β-PDE protein, even when the blots were 
extensively overdeveloped (Figure 3C).
Immunocytochemistry and qPCR quantification of opsin 
expression: As degeneration of the cone OS ultimately 
determines the onset of blindness [58], we performed anti-
S-opsin immunostaining on retinal whole mounts (Figure 
4) at 4-week age intervals and in all four mouse lines. 
We chose S-opsin (Opn1sw), which is also expressed by 
most green cones [59], for immunocytochemistry to allow 
comparison with previous work in rd1 mice. In the 3- to 
4-week-old C3H/HeOu mice, and more apparent in the 3- to 
4-week-old FVB/N mice, the cone OS were relatively small 
and misshaped or lobular compared to those of the healthy 
FVB-Pde6b+ and C3H-Pde6b+ retinas (Figures 1 and 4). 
This is in good agreement with the literature, which states 
that photoreceptor outer and inner segments are never fully 
developed in rd1 mice [17,60]. We performed OS counts in the 
Molecular Vision 2015; 21:811-827 <http://www.molvis.org/molvis/v21/811> © 2015 Molecular Vision 
816
mid-peripheral retinas of 4-week-old rd1 mice, where cone 
density is the highest, and found similar numbers for C3H/
HeOu (8.43±0.9 k/mm2, n=6) and FVB/N (7.08±0.54 k/mm2, 
n=6) mice that did not significantly differ from the counts of 
their seeing congenics (C3H-Pde6b+ (9.45±0.75 k/mm2, n=5; 
FVB-Pde6b+ 8.72±0.68 k/mm2, n=5). In both rd1 lines, the 
OS count decreased with age resulting in a synchronous rise 
in the number of labeled cone cell bodies (Figure 4). The 
latter is most likely a direct consequence of OS loss, where 
opsin naturally destined for the OS now accumulates in the 
soma. As described previously, cone cell bodies labeled with 
opsin staining form dendrite-like processes without any OS 
[13]. OS degeneration progressed at different speeds in the 
FVB/N and C3H/HeOu mice. Although the OS had virtually 
disappeared by 16 weeks of age in the FVB/N mice (0.77±0.77 
k/mm2), they were lost only by week 24 in the C3H/HeOu 
mice (0.81±0.33 k/mm2).
As an additional measure of cone degeneration, we 
quantified S-opsin expression in retinal homogenates. For the 
C3H/HeOu mice, the qPCR data supported the morphological 
findings in that the number of S-opsin transcripts was similar 
to those from the two seeing C3H-Pde6b+ and FVB-Pde6b+ 
strains. However, the S-opsin transcripts were already signif-
icantly reduced in the 4-week-old FVB/N retinas (Figure 3D). 
The reduced S-opsin transcript levels despite the relatively 
Figure 1. Comparison of retinal 
morphologies of 3-week-old and 
23-week-old FVB/N and C3H/
HeOu mice. A–D: Longitudinal 
ret inal cryosect ions stained 
with hematoxylin and eosin (left 
panels) and against S-opsin and 
4’,6-diamidino-2-phenylindole 
(DAPI) (right panels). E–H: Retinal 
whole mounts stained against 
S-opsin. The outer nuclear layer 
(ONL) is two to three cell layers 
thick in 3-week-old C3H/HeOu 
mice (A), whereas the ONL of the 
FVB/N mice had only one layer 
of remnant photoreceptors (B). In 
23-week mice of both lines, the 
ONL was one cell layer thick (C,D). 
At 3 weeks of age, the OS are more 
ordered and cylindrical in the C3H/
HeOu retinas (A,E) compared to the 
FVB/N retinas (B,F). At 23 weeks 
(G,H), the OS are lost, and S-opsin 
is located in the cell bodies. Note 
that the FVB/N retina contains 
markedly fewer cones. Scale bars, 
(A–D) 20 μm, (E–H) 50 μm.
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high OS count in 4-week-old FVB/N mice may indicate more 
advanced pathological progress in the relatively misshaped 
FVB/N compared to the C3H/HeOu cones.
Light responses recorded from retinal ganglion cells: To 
investigate if the morphological discrepancies manifest 
functionally, we recorded extracellular light responses 
from retinal ganglion cells in isolated retinas (Figure 5). In 
both Pde6b+ mouse lines, approximately 90% of all cells 
responded to a step change in light intensity centered over 
the receptive field, 90±5% for C3H-Pde6b+ and 93±4% for 
FVB-Pde6b+. The small fraction of cells that did not respond 
to the light stimulus in the Pde6b+ mice may be cells with 
highly selective trigger features not activated by the flashing 
spot stimulus [61]. In the 4-week-old C3H/HeOu rd1 mice, 
84±11% of the ganglion cells responded to the light stimulus, 
not significantly less than in Pde6b+ retinas. At 8 weeks, 
67±13% of the C3H/HeOu ganglion cells still responded. 
The number of responding cells decreased steadily with 
age, with an eventual loss of light response at the age of 24 
weeks (2±3%; Figure 5), coinciding with OS loss (Figure 
4D). Characteristic slow light responses recorded from 
melanopsin-containing ganglion cells persisted but were not 
included in the analysis [62]. In contrast and in line with our 
morphological observations, significantly fewer ganglion 
cells responded in 4-week-old FVB/N mice (46±12%), and 
their number declined further to 23±8% at 8 weeks, with a 
complete lack of retinal responsiveness by postnatal week 12.
ERG experiments: We performed photopic ERG measure-
ments to confirm the electrophysiological data. Again, the 
seeing FVB-Pde6b+ and C3H-Pde6b+ mice had strong phot-
opic ERG responses to a 100 cd/m2 Xenon strobe flash, with 
average b-wave amplitudes of 178±17 µV and 190±20 µV, 
respectively (Figure 6). In contrast to the patch-clamp experi-
ments, the ERG responses from the 4-week-old C3H/HeOu 
mice were much weaker compared to the seeing congenic 
mice with a significantly reduced b-wave (22±14 µV). Never-
theless, it is remarkable that an ERG was still present in the 
C3H/HeOu mice, since the literature reports loss of an ERG 
in rd1 mice by P21 [18,23]. In line with the literature, no 
ERG was detected at any time point in the FVB/N mice. 
Figure 2. Confirmation of the rd1 genotype of FVB/N and C3H/HeOu mice. A: Presence of the provirus insertion in intron 1 of the PDE6B 
gene tested with Giménez and Montoliu’s three-primer method [54]. The primer pair RD3/RD4 amplifies a 550 bp product only in rd1 lines, 
whereas the primer pair RD3/RD6 amplifies a 400 bp product only in Pde6b+ control mice. B: The nonsense mutation in codon 347 of rd1 
creates a DdeI restriction site. Digestion of a 300 bp PCR product spanning the mutation site with DdeI yielded two diagnostic fragments 
of 106 bp and 139 bp in both rd1 strains. Control: uncut 300 bp PCR product. C: DNA sequencing over Tyr347 (underlined) confirms the 
C→A mutation (*) introducing a stop codon (TAA)  in both rd1 strains.
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The relatively weak—or completely absent—ERG in young 
rd1 mice, which still have a high percentage of responding 
ganglion cells, closely corresponds to clinical observations 
where reduced ERG traces are recorded long before signifi-
cant photoreceptor loss or blindness occurs [63].
Optokinetic response: To go beyond the retina, we behav-
iorally probed for the integrity of the visual reflex circuitry 
by testing the maximum spatial frequency able to trigger 
an optokinetic reflex (OKR). Again, the performances of 
the seeing FVB-Pde6b+ and C3H-Pde6b+ mice were similar 
with maximum spatial frequencies of 0.359±0.037 cyc/deg 
and 0.366±0.011 cyc/deg, respectively, corresponding closely 
to that of C57/BL6 mice [51]. In line with the ERG results, 
the 4-week-old C3H/HeOu mice responded to the moving 
grating, but only to the spatial frequency perceived best by 
mice (0.062±0.026 cyc/deg). The number of C3H/HeOu mice 
with a tracking reflex steadily declined with age until no mice 
responded at 24 weeks (Figure 7). Equal to the ERG experi-
ments, we were not able to measure an OKR response at any 
time point in the FVB/N mice.
In summary, our results suggest delayed photoreceptor 
degeneration in C3H/HeOu mice compared to FVB/N mice. 
Since we observed no significant difference in performance 
between the two seeing Pde6b+ mouse lines, these data indi-
cate variable phenotypic expressivity of the same rd1 muta-
tion, with significantly faster age-dependent degeneration in 
the FVB/N mice compared to the C3H/HeOu mice.
Figure 3. Quantification of Pde6b and S-opsin expression in 3-week old mice. A: Agarose gel electrophoresis of the qPCR products with 
Pde6b specific primers. The 359 bp Pde6b amplicon is detectable in all four mouse strains, however, at markedly different expression levels. 
B: Normalized Pde6b mRNA levels are significantly higher in C3H/HeOu compared to FVB/N mice, but indistinguishable in the two Pde6b+ 
control strains. For each group, n=7–8 retinas from four mice. C: β-PDE immunoreactivity of retinal protein extracts from Pde6b+, rd1, 
and C57BL/6 wild-type mice at postnatal day 21 using an antibody specific for the N-terminal region of β-PDE. An anti-GAPDH antibody 
detecting a band of approximately 37 kDa was used as a loading control. No β-PDE expression is detected in rd1 strains. D: Age-dependent 
S-opsin transcript levels. No significant differences exist between the two Pde6b+ lines and young, 4- to 8-week-old C3H/HeOu mice. In 
contrast, the S-opsin transcripts in the retinas from 4-week-old FVB/N mice were significantly lower than in coeval C3H/HeOu retinas. For 
each group, n=6 retinas from three mice. Error bars indicate standard deviation (SD). The fits are exponential with the R-square values for 
C3H/HeOu and FVB/N at 0.92 and 0.87, respectively.
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DISCUSSION
Clinical severity and disease phenotype often differ among 
individuals with the same genetic mutation, mostly as a result 
of secondary genetic factors [64]. In RP, such variable pheno-
typic expressivity is most noticeable in families in whom 
some affected individuals develop serious visual impair-
ments in early childhood while others live decades with the 
same primary mutation going unnoticed [15]. Despite the 
known importance of secondary genetic traits in hereditary 
photoreceptor degeneration of humans [64] and mice [65,66], 
variable phenotypic expressivity in the rd1 mouse model has 
never been directly addressed. In this study, we emphasize 
the importance of phenotypic expressivity in rd1 mice by 
describing marked differences in the progression of retinal 
degeneration caused by an identical Pde6brd1 mutation in two 
common rd1 strains, C3H/HeOu and FVB/N.
Since the cone photoreceptors are last to degenerate in 
rd1 mice and therefore determine the ultimate time point 
of retinal blindness, we focused on cone degeneration 
and accordingly conducted OKR, patch-clamp, and ERG 
recordings at photopic light intensities and targeted immu-
nocytochemistry and qPCR experiments to cone opsin. All 
methods show a marked difference between the FVB/N and 
C3H/HeOu mice, with relatively fast degeneration in FVB/N 
compared to C3H/HeOu mice. Congenic Pde6b+ variants of 
both mouse lines had normal vision with no inherent differ-
ences that could account for the differences observed in 
the rd1 lines. Sequencing of the Pde6b gene in the FVB/N 
and C3H/HeOu mice confirmed that both strains were rd1, 
suggesting that differences in the progression of degenera-
tion must arise from secondary genetic traits. In other words, 
modifier genes associated with the C3H/HeOu and FVB/N 
genetic backgrounds most probably determine the time point 
and severity of retinal degeneration [64].
Overall, our observed timeline of retinal degeneration in 
C3H/HeOu mice lies somewhere between the published data 
Figure 4. Immunocytochemical detection of cone opsin. Images were always taken from the retinal area with the highest density of labeled 
cones, typically in the mid-periphery of the retina. A: Examples of S-opsin staining in C3H/HeOu retinas demonstrate the progressive loss 
of cone outer segments and a concomitant accumulation of S-opsin in the cell bodies. One misshaped outer segment (clear arrow) and one 
soma without outer segments (OS) are indicated (solid arrow). Age, in weeks, is indicated in the top right of every panel. Scale bar=50 µm. 
B, C: S-opsin staining in wild-type C3H-Pde6b+ (B) and FVB-Pde6b+ (C) retinas were similar. D: Summary graph of OS counts in rd1 
C3H/HeOu and FVB/N mice relative to the Pde6b+ mouse lines. For each group, n=8 retinas from four mice. The fits are exponential with 
the R-square values for C3H/HeOu and FVB/N at 0.94 and 0.8, respectively.
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for rd1 and rd10 mice (Pde6brd10), an alternative RP mouse 
model with a missense mutation in exon 13 of the Pde6b gene 
and delayed onset as well as slower progression of retinal 
degeneration [4,56], while the timeline of degeneration is 
typical rd1 in FVB/N mice. In the C3H/HeOu mice, primary 
rod degeneration and secondary cone OS loss were delayed 
and only nearly complete at 24 weeks. The same trend 
was observed in our physiological experiments. Although 
by postnatal week 12 the FVB/N mice had lost all retinal 
light responses, ganglion cells from the C3H/HeOu retinas 
continued to respond until postnatal week 24. Although the 
4-week-old FVB/N mice had no ERG, ERG was still detected 
in the 4-week-old C3H/HeOu mice. For comparison, previous 
literature report a complete loss of the rd1 ERG by PND21 
[18,23] but ERG responses up to 8 weeks of age in rd10 mice 
[23,56,67,68].
Although the morphological phenotype of C3H mice has 
been stable in the literature over the course of at least 40 years 
[69], if not 90 years [7], the loss of the C3H ERG by P21 must 
be treated with caution since the discovery of a spontaneous 
no b-wave (nob5) mutation in C3H/He lines. This mutation 
in the “parental” C3H/HeJ line was first unmasked when 
it was crossed to a congenic C3H line lacking the Pde6b 
mutation [42,70], as the retinal degeneration concealed the 
nob5 phenotype. The nob5 mutation lies in the Gpr179 gene 
encoding a protein important for ON-bipolar cell activity by 
setting the state of the TRPM1 output channels [70,71]. Lack 
of ON-bipolar cell activity leads to the absence of the b-wave 
in ERG recordings, even under photopic activation where 
cones still generate an a-wave [23]. Since the “parental” C3H/
HeJ line and some of its substrains are known to carry the 
nob5 mutation [72,73], we performed PCR using previously 
published primers [74] and confirmed that our four mouse 
lines are negative for nob5. However, since functional studies 
on rd1 mice are almost non-exclusively performed with ERG, 
we would like to warn researchers using C3H strains about 
drawing premature conclusions about non-functional vision 
as this could be a consequence of the nob5 and not the rd1 
phenotype.
In line with our electrophysiological results, we still 
recorded OKR responses in 4-week-old C3H/HeOu mice, 
while no OKR responses were elicited in the FVB/N mice. 
Since the ganglion cells in the FVB/N mice still responded 
to light at postnatal week 8, we do not attribute the lack of 
ERG and OKR responses to total peripheral blindness but to 
weak retinal output and possibly underdeveloped or deterio-
rated central pathways. This is supported by previous work 
suggesting that rod death precedes full retinal development 
in rd1 mice, which compromises the formation of activity-
dependent cortical pathways [75,76]. In contrast, degenera-
tion in rd10 mice starts after full retinal development [68]. 
Stronger output from young C3H/HeOu retinas may therefore 
Figure 5. Fraction of retinal 
ganglion cells responding to a light 
step in isolated retinas. In both 
seeing Pde6b+ mouse lines, over 
90% of the retinal ganglion cells 
(GCs) responded to light, with no 
significant difference between 
the C3H/He-Pde6b+ and FVB/N-
Pde6b+ lines. At 4 weeks, the frac-
tion of responding GCs in the C3H/
HeOu mice approximated that of 
Pde6b+ mice, while the number of 
responding cells in the age-matched 
FVB/N mice was already signifi-
cantly reduced. No responding 
GCs remained in the FVB/N mice 
at 12 weeks of age compared to 
the C3H/HeOu mice where retinal 
responsiveness disappeared only at 
24 weeks of age. For each group, 
n=6 retinas from six different mice.
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potentially lead to better development or better preservation 
of visual pathways compared to the coeval FVB/N mice.
One potentially important difference between the four 
mouse lines we used is that the FVB/N mice, as opposed 
to the C3H/HeOu and seeing strains, are albinos. Multiple 
studies have reported relatively poor vision in albinos [51,77]. 
This has been partly attributed to the lack of melanin, which 
naturally reduces the amount of light entering and scattering 
within the eye, thus protecting the retina against photodamage 
at high light intensities [78-80]. As the mice were housed 
at light intensities (approximately 7 lux) shown to be “safe” 
for albino mice [50], the photodamage in the FVB/N mice 
in this study is minimal. Other vision problems attributed to 
albinism, but not directly to light damage, include a reduc-
tion in the number of photoreceptor cells, a relative increase 
in the amount of ganglion cells and miswiring of axons in 
the optic chiasm [81-85]. Since different albino strains suffer 
from different degrees of visual impairment, it is hard to 
judge whether these effects are due to albinism itself. Wong 
and Brown (2006) [86] conducted a comprehensive study, 
which compared visual acuity between 14 mouse strains and 
showed that visual acuity was not directly related to albinism 
but stems from other genetic traits. For example, the causative 
locus for poor vision in BALB/c mice is separate from that 
for albinism [86,87]. In addition, expression of retinal degen-
eration is unaffected by albinism [88]. Therefore, although 
a contribution by albinism cannot be absolutely excluded, 
we conclude that albinism itself is unlikely to underlie the 
relatively fast retinal degeneration we observed in the FVB/N 
mice.
The retinas of the 3-week-old FVB/N mice suffered a 
more advanced pathology compared to the coeval C3H/
HeOu retinas. Despite being present at similar numbers, the 
cone OS had more atypical morphologies compared to the 
C3H/HeOu mice. In addition, S-opsin and Pde6b mRNA 
was markedly reduced in the FVB/N retinas. Since β-PDE 
Figure 6. Photopic flash electroret-
inogram (ERG) recordings. In both 
Pde6b+ mouse lines, we recorded 
strong responses, with no signifi-
cant difference in amplitudes. In 
contrast, the ERGs recorded from 
the 4-week-old C3H/HeOu mice 
were markedly weaker with a 
delayed b-wave that disappeared 
in older mice. No ERG response 
was recorded in the FVB/N mice 
at any time point. For each group, 
n=6 mice.
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is specific to rod photoreceptors [55,89], the reduced Pde6b 
mRNA levels in FVB/N suggest a more advanced rod loss. 
This is morphologically apparent from the thin ONL (one-
row thick) observed in 3-week-old FVB/N mice. Therefore, 
the different rates of cone OS degeneration in the two rd1 
strains may be a secondary effect, which reflects relative 
differences in the speed of rod degeneration.
The potential reasons for the decreased Pde6b mRNA 
levels in the FVB/N retinas are manifold, and we can only 
speculate. Aberrant splicing of preRNA and specific degrada-
tion of mutant Pde6b mRNA transcripts have been reported 
to reduce mRNA levels in rd1 mice [55,90]. In theory, such 
mechanisms could also account for the differences in the 
Pde6b mRNA levels of  FVB/N and C3H/HeOu retinas if they 
manifested to different degrees in the two lines. However, 
Pde6b transcription itself could vary in the two rd1 lines. 
Although Pde6b mRNA was detected, no β-PDE protein 
was detectably expressed in any of the two rd1 retinas. This 
finding is in line with previous reports on rd1 [56] and could 
be the consequence of nonsense-mediated Pde6b mRNA 
decay [55], upregulation of specific micro-RNAs mediating 
Pde6b translation block, or cotranslational β-PDE modifica-
tions such as known myristoylation-reducing protein activity 
and stability. Although the β-PDE protein was detected in 
rd10 retinas [56] and not in rd1 retinas, marginal expression 
of the truncated β-PDE protein cannot be exclusively ruled 
out. Such truncated protein may exhibit some function as it 
retains the inhibitory γ-subunit-binding site and the cGMP 
binding domains. Therefore, the observed differences in 
photoreceptor degeneration in the FVB/N and C3H/HeOu 
mice could speculatively still arise from differences in β-PDE 
protein activity or stability. Additional Pde6b mutations can 
modify β-PDE activity and rd1 phenotype. For example, the 
chemically induced H620Q missense mutation located in 
the β-PDE catalytic domain was reported to lead to a slower 
onset of retinal degeneration in heterozygous Pde6bH620Q/rd1 
mice compared to homozygous rd1 mice [9]. Similarly, the 
artificially introduced homozygous H258N missense muta-
tion in the cGMP-binding domain of β-PDE led to photore-
ceptor rescue in rd1 mice [91]. Interestingly, the degree of 
rescue depended on the genetic background. Mutations in 
other genomic loci than the Pde6b gene itself can therefore 
Figure 7. Maximum spatial acuity 
of the optokinetic ref lex (OKR) 
responses. Although both Pde6b+ 
mouse lines responded to spatial 
frequencies characteristic of wild-
type mice with no significant 
difference between the two mouse 
lines, only young 4-week-old C3H/
HeOu mice reliably responded 
with a tracking reflex and only to 
relatively low spatial frequencies 
(0.062±0.02 cyc/deg). The number 
of C3H/HeOu mice with an OKR 
response decreased steadily with 
age and approached zero at 24 
weeks. The FVB/N mice did not 
have a detectable OKR at any 
age. The fit is exponential with an 
R-square value of 0.92.
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potentially influence the rd1 phenotype. For example, a point 
mutation in the mitochondrial mt-ATP8 gene [46] of FVB/N 
mice was attributed to increased oxidative stress [47,48], 
which could, at least in part, contribute to accelerated photo-
receptor death. Alternatively, the cone OS in the C3H/HeOu 
mice might be better preserved by an unknown mechanism. 
It has recently been shown that miR-182 and miR-183 foster 
cone OS maintenance [92]. Different levels of miRNAs in the 
two rd1 strains could consequently underlie different rates of 
OS degeneration. Since the modifier genes responsible for 
the different phenotypes observed in FVB/N and C3H/HeOu 
mice may lie in any genomic region, it might be necessary to 
identify trait loci and candidate genes as the next step toward 
identifying genes associated with phenotypic expressivity in 
rd1 mice [93].
Since retinal degeneration in FVB/N mice overlaps with 
retinal development and FVB/N mice may also have rela-
tively underdeveloped central visual pathways, they may be 
a less useful RP model for vision recovery studies compared 
to C3H/HeOu mice. In light of the results presented in this 
study, we assume similar variable phenotypic expressivity 
between rd10 mouse lines. Since rd10 mice equally have 
a mutation in the Pde6b gene, degeneration is likely to be 
much slower on the C3H/HeOu background compared to the 
FVB/N background. In conclusion, our results highlight the 
important role of genetic background in the rd1 pathology 
promoting a more accurate comparison and interpretation 
of results collected from different rd mouse lines. To avoid 
variation resulting from differences in genetic background 
altogether, it may be sensible to use only one rd1 mouse line 
in preclinical studies. Additionally, our results move toward 
identifying and understanding secondary genetic traits that 
govern variable phenotypic expressivity in patients with RP.
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